PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: AdvaCare Pharma

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

AdvaCare and Matrix Uganda Releasing New Paracetamol Brand 'Para' in East African Markets - A new Paracetamol brand will be released by Advacare and the Ugandan company Matrix. The brand name will be
AdvaCare and Matrix Uganda Releasing New Paracetamol Brand 'Para' in East African Markets

 

NewswireToday - /newswire/ - Shanghai, China, 2012/06/18 - A new Paracetamol brand will be released by Advacare and the Ugandan company Matrix. The brand name will be "Para" - AdvacarePharma.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

AdvaCare is releasing a new Paracetamol brand with the partnership of Matrix Uganda, a leading distributor in the East Africa markets, under the brand name of “Para." Paracetamol is a widely used over-the-counter analgesic which is a pain reliever and antipyretic which is a fever reducer. It is commonly used for the relief of headaches and other minor aches and pains and is a major ingredient in numerous cold and flu remedies. In combination with opioid analgesics, paracetamol can also be used in the management of more severe pain such as post-surgical pain and providing palliative care in advanced cancer patients.

After rapidly expanding in key markets throughout 2011, AdvaCare is taking an even bigger step forward in Uganda and the East African markets. AdvaCare is now considered one of the leading providers of pharmaceuticals and medical supplies in these markets. AdvaCare has successfully distributed not only medical supplies, but also a large range of finished pharmaceuticals that includes antimalarials and veterinary products for the region.

All AdvaCare distributors and importers meet our requirements ensuring capable distribution networks, sound financial stability, and ethical business practices. Our reputation is founded not only on our quality and affordable GMP approved products and competent employees, but also on our partners and distributors ability to meet the same standards.

AdvaCare (advacarepharma.com) is a leading pharmaceutical and healthcare products company. With over 60 branded products sold worldwide and numerous generics produced under our customers' brands, AdvaCare supplies distributors, governments and hospitals with the products they need for their markets. Our wide product range, including pharmaceuticals, veterinary products, active pharmaceutical ingredients, medical supplies, and diagnostic test kits allows us to scale our resources resulting in added value for our customers and ultimately the end user. AdvaCare focuses on the best value for our customers while upholding the highest quality standards.Contact us at sales[.]advacarepharma.com

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: AdvaCare Pharma

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


AdvaCare and Matrix Uganda Releasing New Paracetamol Brand 'Para' in East African Markets

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Bradley Johnson - AdvacarePharma.com 
+86 2161473476 sales[.]advacarepharma.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any AdvaCare Pharma securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From AdvaCare Pharma / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

First Pulmonary Embolism Patients in Hong Kong Treated with the EKOS® System
Ipsen to Acquire Oncology Assets from Merrimack Pharmaceuticals
FDA Grants Genentech’s Cancer Immunotherapy Tecentriq® (Atezolizumab) Priority Review in Additional Type of Advanced Bladder Cancer
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) for Myopic Choroidal Neovascularization
Sugar Element of Keratan Sulfate Halts the Progress of Emphysema Finds RIKEN
Exelixis and Ipsen Amend Exclusive Licensing Agreement for the Commercialization and Development of Cabozantinib to Include Canada
FDA Extends Review of Application for OCREVUS™ (Ocrelizumab)
MDxHealth Announces AceCGT Life Science Limited as the Exclusive Distributor for SelectMDx in Hong Kong and Macao China
Pulse Certified As A Level Four Multichannel Content Agency by Veeva Systems
BD Launches Advanced Prefillable Syringe for Higher Volume Injection of Biologics
Sartorius Announces Expansion of Sartorius Stedim Cellca
Frost & Sullivan Commends Nemaura for Developing Superior Transdermal Drug Delivery Technology Platforms, the Memspatch and Micropatch
Greenphire Sponsors Second Annual Clinical Trial Agreements, Investigator Payments and Fair Market Value Meeting
BD Integrating Technology, Expertise and Services to Provide Comprehensive Medication Management
Genentech’s Gazyva Helped People with Previously Untreated Follicular Lymphoma Live Significantly Longer

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  1Click Games

Visit  Intrinsic Executive Search Ltd





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)